🇺🇸 FDA
Patent

US 6926909

Chrono delivery formulations and method of use thereof

expired A61KA61K31/554A61K9/2081

Quick answer

US patent 6926909 (Chrono delivery formulations and method of use thereof) held by Elite Laboratories, Inc. expires Mon Aug 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Elite Laboratories, Inc.
Grant date
Tue Aug 09 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/554, A61K9/2081, A61K9/5026, A61K9/5078